|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.40 USD | +2.32% |
|
+15.36% | +1.56% |
| 12-22 | RAPT Therapeutics, Inc.(NasdaqGM:RAPT) added to S&P Biotechnology Select Industry Index | CI |
| 12-21 | RAPT Therapeutics, Inc.(NasdaqGM:RAPT) added to NASDAQ Biotechnology Index | CI |
| Capitalization | 953M 816M 759M 708M 1.32B 85.92B 1.42B 8.74B 3.44B 41.1B 3.57B 3.5B 151B | P/E ratio 2025 * |
-14.9x | P/E ratio 2026 * | -10.7x |
|---|---|---|---|---|---|
| Enterprise value | 542M 464M 432M 403M 752M 48.86B 807M 4.97B 1.95B 23.38B 2.03B 1.99B 85.71B | EV / Sales 2025 * |
-
| EV / Sales 2026 * | - |
| Free-Float |
26% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: RAPT Therapeutics, Inc.
More recommendations
More press releases
| 1 day | +2.32% | ||
| 1 week | +15.36% | ||
| Current month | +1.56% | ||
| 1 month | -6.52% | ||
| 3 months | +28.41% | ||
| 6 months | +306.62% | ||
| Current year | +1.56% |
| 1 week | 31.08 |  | 34.52 |
| 1 month | 29.77 | | 37.75 |
| Current year | 29.77 | | 34.52 |
| 1 year | 5.67 | | 42.39 |
| 3 years | 5.67 | | 251.6 |
| 5 years | 5.67 | | 346.08 |
| 10 years | 5.67 | | 409.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 54 | 31/07/2015 |
Rodney Young
DFI | Director of Finance/CFO | 63 | 01/12/2019 |
Nipun Davar
CTO | Chief Tech/Sci/R&D Officer | - | 12/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Brian Wong
BRD | Director/Board Member | 54 | 31/07/2015 |
Linda Kozick
BRD | Director/Board Member | 68 | 30/11/2016 |
Michael Giordano
BRD | Director/Board Member | 68 | 31/12/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.74% | 0.02% | 324 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.32% | +15.36% | +225.76% | -83.83% | 953M | |
| -3.14% | -1.73% | +3.87% | +82.75% | 48.01B | |
| -0.40% | +4.35% | +84.93% | +8.53% | 41.97B | |
| -4.69% | -4.27% | +157.04% | +768.57% | 35.77B | |
| +2.33% | +5.50% | -16.83% | -31.61% | 25.64B | |
| -0.92% | +7.56% | +38.32% | -21.04% | 20.81B | |
| +6.39% | +19.15% | +136.33% | -41.48% | 19.92B | |
| -13.41% | -2.29% | -4.54% | +323.88% | 13.14B | |
| -3.73% | +3.50% | +118.77% | +163.76% | 14.9B | |
| -2.78% | +10.09% | +182.59% | - | 14.63B | |
| Average | -0.53% | +5.56% | +92.63% | +129.95% | 23.58B | |
| Weighted average by Cap. | -1.34% | +2.98% | +72.30% | +164.45% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -78.27M -67.02M -62.33M -58.11M -109M -7.05B -116M -718M -282M -3.37B -294M -288M -12.37B | -107M -91.5M -85.09M -79.33M -148M -9.63B -159M -980M -385M -4.61B -401M -393M -16.89B |
| Net Debt | -411M -352M -327M -305M -570M -37.05B -612M -3.77B -1.48B -17.73B -1.54B -1.51B -64.99B | -316M -271M -252M -235M -438M -28.47B -470M -2.9B -1.14B -13.62B -1.18B -1.16B -49.94B |
More financial data
* Estimated data
Employees
60
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/01/26 | 34.40 $ | +2.32% | 177,967 |
| 09/01/26 | 33.62 $ | +7.76% | 338,090 |
| 08/01/26 | 31.20 $ | -3.76% | 311,007 |
| 07/01/26 | 32.42 $ | +5.16% | 445,998 |
| 06/01/26 | 30.83 $ | +3.39% | 288,301 |
Delayed Quote Nasdaq, January 12, 2026 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
34.40USD
Average target price
68.75USD
Spread / Average Target
+99.85%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RAPT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition